Evidence map›Paper›PMID 34145978›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2021

Intelligent Molybdenum Disulfide Complexes as a Platform for Cooperative Imaging-Guided Tri-Mode Chemo-Photothermo-Immunotherapy.

Wei Hu, Tingting Xiao, Du Li, Yu Fan, Lingxi Xing, Xipeng Wang, Yulin Li, Xiangyang Shi, Mingwu Shen

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 80 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Wei HuState Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Chemistry, Chemical Engineering and Biotechnology, Donghua University, Shanghai, 201620, P. R. China.
Tingting XiaoState Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Chemistry, Chemical Engineering and Biotechnology, Donghua University, Shanghai, 201620, P. R. China.
Du LiState Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Chemistry, Chemical Engineering and Biotechnology, Donghua University, Shanghai, 201620, P. R. China.
Yu FanState Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Chemistry, Chemical Engineering and Biotechnology, Donghua University, Shanghai, 201620, P. R. China.
Lingxi XingDepartment of Gynecology and Obstetrics, XinHua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, P. R. China.
Xipeng WangDepartment of Gynecology and Obstetrics, XinHua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, P. R. China.
Yulin LiThe Key Laboratory for Ultrafine Materials of Ministry of Education, State Key Laboratory of Bioreactor Engineering, Engineering Research Center for Biomedical Materials of Ministry of Education, School of Materials Science and Engineering, East China University of Science and Technology, Shanghai, 200237, P. R. China.
Xiangyang ShiState Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Chemistry, Chemical Engineering and Biotechnology, Donghua University, Shanghai, 201620, P. R. China.ORCID 0000-0001-6785-6645
Mingwu ShenState Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Chemistry, Chemical Engineering and Biotechnology, Donghua University, Shanghai, 201620, P. R. China.ORCID 0000-0002-1065-0854
Donghua University · CNShanghai Jiao Tong University · CNEast China University of Science and Technology · CN

Funding

Fundamental Research Funds for the Central UniversitiesNational Key R&D Program 2017YFE0196200National Natural Science Foundation of China 21773026National Natural Science Foundation of China 81761148028National Natural Science Foundation of China 81801704Science and Technology Commission of Shanghai Municipality 18YF1415300Science and Technology Commission of Shanghai Municipality 19410740200Science and Technology Commission of Shanghai Municipality 19XD1400100Science and Technology Commission of Shanghai Municipality 20520710300
6 · The paper itself

Abstract

Design of new nanoplatforms that integrates multiple imaging and therapeutic components for precision cancer nanomedicine remains to be challenging. Here, a facile strategy is reported to prepare polydopamine (PDA)-coated molybdenum disulfide (MoS

Indexed as

AnimalsAntineoplastic AgentsCell Line, TumorCombined Modality TherapyDisease Models, AnimalDisulfidesImmunotherapyMiceMolybdenumNanoparticle Drug Delivery SystemNeoplasmsPhotoacoustic TechniquesPhototherapyRadiography, InterventionalTomography, X-Ray ComputedAntineoplastic AgentsDisulfidesMolybdenummolybdenum disulfideNanoparticle Drug Delivery Systemimmunogenic cell deathmolybdenum disulfidemultimode imagingpolydopaminetri-mode chemophotothermo-immunotherapy of tumors

Identifiers

PMID34145978
PMCPMC8292874
OpenAlexW3167481568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.